The Delhi High Court said the government can only 'monitor' the minimum retail price (MRP) of non-scheduled formulations under drugs (price control) order. The court said the government can neither fix nor revise the price of the drug.
The court said that in case there is an increase in the MRP beyond this limit then it is manufacturer's liability to deposit the overcharged amount along with interest from the date of transgression, and reduction of the MRP of the non-scheduled formulation to the level of 10% of MRP for the next 12 months.
On November 13, India's drug pricing authority — the National Pharmaceutical Pricing Authority (NPPA) brought 33 fixed-dose combination drugs under its price regulation. A notification released by the regulator said drug manufacturers are allowed to charge Goods and Services Tax (GST) only if they have made the payment or it is payable to the government on the retail price mentioned.
First Published: Nov 14, 2023 10:05 AM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM